Clinical Trial Update: Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Mannan-binding lectin substitution in MBL-deficient children with chemotherapy-induced neutropenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Mannan-binding Lectin Deficiency
• Neutropenia

Drugs mentioned

• Mannan-binding lectin substitution (mannan-binding lectin)

Snippet

Sponsor: Prothya Biosolutions | Conditions: MBL-Deficient, Neutropenia | Phase 2 | Status: COMPLETED